What's new in hematopathology 2023: updates on mature T-cell neoplasms in the 5th edition of the WHO classification.

IF 1.7 Q3 PATHOLOGY

Journal of Pathology and Translational Medicine Pub Date : 2023-07-01 DOI:10.4132/jptm.2023.06.15

Mario L Marques-Piubelli, Roberto N Miranda

引用次数: 0

Abstract

The overview of the upcoming Blue Book of the 5th edition of the World Health Organization Classification of Hematolymphoid Tumors was published in Leukemia in June 2022. The updates on mature T-/NK-cell lymphomas and leukemias are organized in nine groups based on cell of origin, morphology, clinical scenario, and localization, and are highlighted in this newsletter.

Abstract Image

查看原文本刊更多论文

《2023年血液病新进展:世卫组织第五版分类中关于成熟t细胞肿瘤的最新情况》

即将出版的世界卫生组织第五版《血淋巴肿瘤分类》蓝皮书概述已于2022年6月在《白血病》上发表。成熟T / nk细胞淋巴瘤和白血病的最新进展根据细胞起源、形态、临床情况和定位分为九组，并在本通讯中重点介绍。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Pathology and Translational Medicine PATHOLOGY-

CiteScore

5.00

自引率

4.20%

发文量

审稿时长

14 weeks

期刊介绍： The Journal of Pathology and Translational Medicine is an open venue for the rapid publication of major achievements in various fields of pathology, cytopathology, and biomedical and translational research. The Journal aims to share new insights into the molecular and cellular mechanisms of human diseases and to report major advances in both experimental and clinical medicine, with a particular emphasis on translational research. The investigations of human cells and tissues using high-dimensional biology techniques such as genomics and proteomics will be given a high priority. Articles on stem cell biology are also welcome. The categories of manuscript include original articles, review and perspective articles, case studies, brief case reports, and letters to the editor.